Conquering Diseases

Study Of Remedesivir For Hospitalized Children With Covid-19


Seeking boys and girls under the age of 18 who are hospitalized for a COVID-19 infection for a study of the safety and effectiveness of remdesivir for COVID-19 infection in children.


We are studying the safety and effectiveness of Remdesivir for children hospitalized with COVID-19. The investigational drug has been approved for use in adults, but has not been studied in children.

What we're hoping for

We hope that the Remdesivir will be safe and effective for use in children hospitalized with COVID-19. We also hope to find the best dose of the investigational drug.

Additional Information Identifier: NCT04431453

 Principal Investigator

Katherine  Luzuriaga, MD

University of Massachusetts Medical School

 Study Contact

The Clinical Research  Center



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655